By Counterforce Health Team in Blenrep (belantamab mafodotin) —

How to Get Blenrep (Belantamab Mafodotin) Covered by Cigna in Illinois: Complete Timeline and Appeal Guide

Answer Box: Getting Blenrep Covered by Cigna in Illinois

Current Status: Blenrep (belantamab mafodotin) received FDA approval in July 2025 for relapsed/refractory multiple myeloma after previous market withdrawal. Timeline: Cigna typically processes specialty drug prior authorizations within 1-3 business days through Express Scripts/Accredo. First Step: Work with your oncologist to submit a formulary exception request documenting your prior therapy history (at least two lines including a proteasome inhibitor and immunomodulatory agent). Illinois Advantage: Strong external review rights with 4-month filing window and binding independent physician review if internal appeals fail.

Table of Contents

  1. What Affects Blenrep Approval Timing
  2. Pre-Submission Preparation (0-2 Days)
  3. Submission to Initial Review (1-5 Days)
  4. Additional Information Requests (1-7 Days)
  5. Decision Window & Outcomes
  6. If Denied: Appeals in Illinois
  7. Renewal Cycles
  8. Timeline Visual Guide
  9. Time-Saving Tips
  10. FAQ

What Affects Blenrep Approval Timing

Several factors influence how quickly Cigna approves Blenrep (belantamab mafodotin) coverage in Illinois:

Benefit Structure: Cigna manages specialty drugs through Express Scripts/Accredo specialty pharmacy, which can expedite electronic prior authorization submissions to 1-2 business days compared to standard timelines.

Clinical Complexity: Blenrep requires documentation of specific prior therapy failures and REMS program enrollment due to ocular toxicity risks. Your oncologist must demonstrate you've received at least two prior lines of therapy including a proteasome inhibitor and immunomodulatory agent.

Documentation Completeness: Electronic submissions through CoverMyMeds or your provider's EHR integration process significantly faster than phone or fax submissions. Complete documentation upfront prevents requests for additional information that can add 1-7 days to the process.

Note: Due to the Change Healthcare outage that affected Illinois from February 21, 2024 to April 29, 2025, any prior authorizations submitted during this period needed resubmission if the patient continues to need the medication.

Pre-Submission Preparation (0-2 Days)

Clinical Documentation Checklist

Your healthcare team should gather:

  • Prior therapy history: Documentation of at least two previous treatment lines
  • Treatment failures: Records showing inadequate response or intolerance to proteasome inhibitors and immunomodulatory agents
  • Current disease status: Recent imaging, lab results, and disease progression notes
  • REMS enrollment: Confirmation of eye care monitoring plan per FDA requirements

Insurance Verification

  • Confirm your Cigna plan covers specialty medications
  • Verify if Blenrep requires formulary exception status
  • Check if step therapy protocols apply to your specific plan

Counterforce Health helps patients and providers streamline this documentation process by analyzing denial patterns and creating targeted, evidence-backed appeals that align with payer-specific requirements. Their platform can identify the exact clinical evidence needed for Cigna approvals and draft compelling medical necessity letters.

Submission to Initial Review (1-5 Days)

Electronic Submission (Fastest Option)

Cigna processes electronic prior authorizations through multiple platforms:

  • CoverMyMeds (primary platform)
  • Evicore by Evernorth Pharmacy Drug Portal for Express Scripts PBM
  • MyAccredoPatients.com for Accredo specialty pharmacy
  • EHR integration (varies by provider system)

Expected Timeline: 1-2 business days for electronic submissions vs. 1-3 days for phone/fax.

What Reviewers Check First

  1. Eligibility verification: Active Cigna coverage and specialty pharmacy enrollment
  2. Clinical criteria: Prior therapy documentation and failure/intolerance evidence
  3. REMS compliance: Eye care monitoring plan confirmation
  4. Formulary status: Whether exception request is needed

Illinois-Specific Requirements

Illinois law requires insurers to process internal appeals within specific timeframes:

  • Pre-service requests: 15 business days for standard review
  • Expedited reviews: 24 hours for urgent medical situations

Additional Information Requests (1-7 Days)

If Cigna requests additional documentation, respond quickly to avoid delays:

Common Requests for Blenrep

  • Detailed prior therapy timeline with specific drug names, doses, and duration
  • Documentation of treatment failures or adverse events
  • Current performance status and disease burden assessment
  • Ophthalmologic baseline evaluation results

How to Respond Quickly

  • Use secure provider portals when possible
  • Submit complete documentation packages rather than piecemeal responses
  • Include cover letter summarizing key clinical points
  • Follow up within 24-48 hours to confirm receipt

Decision Window & Outcomes

Typical Approval Timeline

Standard Review: 1-3 business days once complete documentation received Expedited Review: 1 calendar day for urgent cases

Reading Approval Letters

Approved authorizations will specify:

  • Approved quantity and refills
  • Duration of authorization (typically 6-12 months for specialty drugs)
  • Required specialty pharmacy (usually Accredo for Cigna)
  • Any ongoing monitoring requirements

If Denied: Appeals in Illinois

Illinois provides robust appeal rights for Cigna members through the Health Carrier External Review Act.

Internal Appeal Process

Timeline: Must file within 180 days of denial notice Review Period: 15 business days for pre-service requests; 24 hours for expedited Required Elements:

  • Written appeal request
  • Clinical rationale for medical necessity
  • Supporting documentation from treating physician

External Review (Independent Physician Review)

If internal appeal fails, Illinois law guarantees independent external review:

Filing Deadline: 4 months from final adverse determination Process: Independent Review Organization assigns board-certified specialist Timeline: Decision within 5 business days of receiving all materials Cost: No fee to patients; insurers pay review costs

Critical Illinois Deadline: You have only 30 days to request external review if Cigna hasn't decided your internal appeal within 30 days of submission.

Contact Information

  • Illinois Department of Insurance: (877) 527-9431
  • Illinois Attorney General Health Care Helpline: (877) 305-5145

Renewal Cycles

When to Reauthorize

Most Cigna specialty drug authorizations require renewal every 6-12 months. Submit renewal requests 30 days before expiration with updated clinical documentation.

What Speeds Renewals

  • Documented treatment response or disease stability
  • Continued medical necessity evidence
  • Updated eye examination results (required for Blenrep REMS)
  • No significant changes to treatment plan

Timeline Visual Guide

Phase Timeline Key Actions Expected Outcome
Preparation 0-2 days Gather clinical documentation, verify insurance Ready to submit
Initial Submission Day 1 Electronic PA submission via CoverMyMeds/EHR Acknowledgment received
Review Process 1-3 days Cigna clinical review, REMS verification Approval or info request
Additional Info 1-7 days Respond to any documentation requests Final decision
Internal Appeal 15 days Submit appeal if denied Approval or final denial
External Review 45 days Independent physician review Binding decision

Time-Saving Tips

Portal Usage

  • Use electronic submission platforms exclusively when possible
  • Set up provider portal accounts for real-time status tracking
  • Enable automatic notifications for status updates

Bundled Evidence Strategy

Submit comprehensive evidence packages including:

  • Complete prior therapy timeline
  • Relevant clinical guidelines citations
  • Current disease assessment
  • REMS compliance documentation

Direct Specialty Routing

Work directly with Accredo specialty pharmacy for Cigna members to streamline the authorization and fulfillment process.

Counterforce Health's platform can automate much of this evidence gathering and submission process, helping providers create targeted appeals that address Cigna's specific clinical criteria for Blenrep approval.

FAQ

How long does Cigna prior authorization take for Blenrep in Illinois? Standard processing takes 1-3 business days for electronic submissions. Expedited reviews are completed within 24 hours for urgent medical situations.

What if Blenrep is not on Cigna's formulary? Request a formulary exception with clinical rationale documenting medical necessity and prior therapy failures.

Can I request an expedited appeal in Illinois? Yes, expedited appeals are available when delays would seriously jeopardize your health. These must be decided within 24 hours of receipt.

What happens if my internal appeal is denied? Illinois law guarantees external review by an independent physician. You have 4 months to file for external review after receiving the final denial.

Does step therapy apply to Blenrep? This depends on your specific Cigna plan. Your oncologist can request step therapy exceptions if other required medications are contraindicated or have failed.

What clinical evidence strengthens my appeal? Document specific prior therapy failures, current disease burden, treatment goals, and alignment with FDA-approved indications for relapsed/refractory multiple myeloma.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions depend on individual plan benefits and clinical circumstances. Always consult with your healthcare provider and insurance plan for specific coverage determinations. For assistance with complex appeals, consider working with patient advocacy organizations or Counterforce Health, which specializes in turning insurance denials into successful, evidence-backed appeals.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.